Press Releases
- Active Biotech receives tasquinimod milestone payment from Ipsen for 10TASQ10 study October 9, 2013 07:36 (CEST)
- Active Biotech receives tasquinimod milestone payment from Ipsen for 10TASQ10 study October 9, 2013 07:30 (CEST)
- New Data Presented at 29th ECTRIMS Congress Reinforce the Clinical Profile of Investigational Laquinimod on Disease Progression and Inflammation in Relapsing-Remitting Multiple Sclerosis October 4, 2013 15:36 (CEST)
- New Data Presented at 29th ECTRIMS Congress Reinforce the Clinical Profile of Investigational Laquinimod on Disease Progression and Inflammation in Relapsing-Remitting Multiple Sclerosis October 4, 2013 15:30 (CEST)
- Newly Published Phase III Exploratory Analysis Suggests Investigational Oral Laquinimod for Multiple Sclerosis May Reduce Brain Damage Caused by Neurodegeneration October 1, 2013 14:00 (CEST)
- Active Biotech's project ANYARA will be presented at the European Cancer Congress 2013 September 12, 2013 10:05 (CEST)
- Active Biotech's project ANYARA will be presented at the European Cancer Congress 2013 September 12, 2013 10:00 (CEST)
- Active Biotech to Present at the Rodman & Renshaw Annual Global Investment Conference September 5, 2013 08:37 (CEST)
- Active Biotech to Present at the Rodman & Renshaw Annual Global Investment Conference September 5, 2013 08:30 (CEST)
- Active Biotech AB Interim Report January - June 2013 August 7, 2013 08:30 (CEST)